USPTO serial 99479274
BIOVECTRA
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- KONSCHAK, CARL A
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with BIOVECTRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew Roppel
Andrew Roppel Holland & Hart LLPAttn: Trademark DocketingP.O. Box 8749Denver, CO 80201-8749Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compositions, reagents, chemical additives, and biochemical preparations for use in the manufacture of pharmaceuticals and biopharmaceuticals; Chemical compositions, reagents, chemical additives, and biochemical preparations, all for scientific research use in the fields of pharmaceuticals and biopharmaceuticals | ACTIVE | — |
| 005 | Chemical reagents for pharmaceutical purposes; Chemical reagents for medical purposes; Biological reagents for medical purposes; Diagnostic reagents for medical use | ACTIVE | — |
| 040 | Custom manufacturing in the field of biopharmaceuticals and pharmaceuticals, namely, chemical additives and reagents; Manufacturing process consulting; Providing technical information in the field of pharmaceutical manufacturing; Custom manufacturing of chemical additives, reagents, pharmaceutical additives, pharmaceuticals, biopharmaceuticals, medicines, and medicaments for others | ACTIVE | — |
| 042 | Development of chemical additives, reagents, pharmaceutical additives, pharmaceuticals, biopharmaceuticals, medicines, medicaments for others; Research in the field of biopharmaceuticals and pharmaceuticals; Engineering services; Laboratory services using fermentation for biomanufacturing; Biochemical research and analysis; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biopharmaceuticals and pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named BIOVECTRA
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 23, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 23, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 17, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 11, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 11, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 11, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 7, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 12, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2025 | NWAP | NEW APPLICATION ENTERED | — |